These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 34766620)

  • 21. A pharmaceutical industry perspective on microphysiological kidney systems for evaluation of safety for new therapies.
    Phillips JA; Grandhi TSP; Davis M; Gautier JC; Hariparsad N; Keller D; Sura R; Van Vleet TR
    Lab Chip; 2020 Feb; 20(3):468-476. PubMed ID: 31989145
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Re-Engineering RNA Molecules into Therapeutic Agents.
    Egli M; Manoharan M
    Acc Chem Res; 2019 Apr; 52(4):1036-1047. PubMed ID: 30912917
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Microphysiological Systems: A Pathologist's Perspective.
    Sura R; Van Vleet T; Berridge BR
    Vet Pathol; 2020 May; 57(3):358-368. PubMed ID: 32180532
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Organic nanotubes for drug loading and cellular delivery.
    Wakasugi A; Asakawa M; Kogiso M; Shimizu T; Sato M; Maitani Y
    Int J Pharm; 2011 Jul; 413(1-2):271-8. PubMed ID: 21540092
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Liver as a target for oligonucleotide therapeutics.
    Sehgal A; Vaishnaw A; Fitzgerald K
    J Hepatol; 2013 Dec; 59(6):1354-9. PubMed ID: 23770039
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pharmacokinetics-On-a-Chip: In Vitro Microphysiological Models for Emulating of Drugs ADME.
    Ramadan Q; Fardous RS; Hazaymeh R; Alshmmari S; Zourob M
    Adv Biol (Weinh); 2021 Sep; 5(9):e2100775. PubMed ID: 34323392
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Biology-inspired microphysiological systems to advance patient benefit and animal welfare in drug development.
    Marx U; Akabane T; Andersson TB; Baker E; Beilmann M; Beken S; Brendler-Schwaab S; Cirit M; David R; Dehne EM; Durieux I; Ewart L; Fitzpatrick SC; Frey O; Fuchs F; Griffith LG; Hamilton GA; Hartung T; Hoeng J; Hogberg H; Hughes DJ; Ingber DE; Iskandar A; Kanamori T; Kojima H; Kuehnl J; Leist M; Li B; Loskill P; Mendrick DL; Neumann T; Pallocca G; Rusyn I; Smirnova L; Steger-Hartmann T; Tagle DA; Tonevitsky A; Tsyb S; Trapecar M; Van de Water B; Van den Eijnden-van Raaij J; Vulto P; Watanabe K; Wolf A; Zhou X; Roth A
    ALTEX; 2020; 37(3):365-394. PubMed ID: 32113184
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Application of Immunocompetent Microphysiological Systems in Drug Development: Current Perspective and Recommendations.
    Wang X; Kopec AK; Collinge M; David R; Grant C; Hardwick RN; Navratil A; Patel N; Rowan W; Marshall N
    ALTEX; 2022 Aug; 40(2):314–336. PubMed ID: 36044561
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Preclinical pharmacokinetics: an approach towards safer and efficacious drugs.
    Singh SS
    Curr Drug Metab; 2006 Feb; 7(2):165-82. PubMed ID: 16472106
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Quantitative Systems Pharmacology Approaches Applied to Microphysiological Systems (MPS): Data Interpretation and Multi-MPS Integration.
    Yu J; Cilfone NA; Large EM; Sarkar U; Wishnok JS; Tannenbaum SR; Hughes DJ; Lauffenburger DA; Griffith LG; Stokes CL; Cirit M
    CPT Pharmacometrics Syst Pharmacol; 2015 Oct; 4(10):585-94. PubMed ID: 26535159
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Progress in developing microphysiological systems for biological product assessment.
    Mansouri M; Lam J; Sung KE
    Lab Chip; 2024 Feb; 24(5):1293-1306. PubMed ID: 38230512
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Production, Characterization and Application of Oxide Nanotubes on Ti-6Al-7Nb Alloy as a Potential Drug Carrier.
    Łosiewicz B; Stróż A; Osak P; Maszybrocka J; Gerle A; Dudek K; Balin K; Łukowiec D; Gawlikowski M; Bogunia S
    Materials (Basel); 2021 Oct; 14(20):. PubMed ID: 34683734
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Current status of MPS research toward social implementation].
    Sakai Y; Kimura H
    Nihon Yakurigaku Zasshi; 2022; 157(5):330-334. PubMed ID: 36047147
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Clinical Applications of Single-Stranded Oligonucleotides: Current Landscape of Approved and In-Development Therapeutics.
    Scharner J; Aznarez I
    Mol Ther; 2021 Feb; 29(2):540-554. PubMed ID: 33359792
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Tissue-Specific Delivery of Oligonucleotides.
    Xia X; Pollock N; Zhou J; Rossi J
    Methods Mol Biol; 2019; 2036():17-50. PubMed ID: 31410789
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The National Institutes of Health Microphysiological Systems Program focuses on a critical challenge in the drug discovery pipeline.
    Sutherland ML; Fabre KM; Tagle DA
    Stem Cell Res Ther; 2013; 4 Suppl 1(Suppl 1):I1. PubMed ID: 24565163
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Microphysiological Systems (Tissue Chips) and their Utility for Rare Disease Research.
    Low LA; Tagle DA
    Adv Exp Med Biol; 2017; 1031():405-415. PubMed ID: 29214585
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Microphysiological lung models to evaluate the safety of new pharmaceutical modalities: a biopharmaceutical perspective.
    Ainslie GR; Davis M; Ewart L; Lieberman LA; Rowlands DJ; Thorley AJ; Yoder G; Ryan AM
    Lab Chip; 2019 Sep; 19(19):3152-3161. PubMed ID: 31469131
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Imaging microphysiological systems: a review.
    Peel S; Jackman M
    Am J Physiol Cell Physiol; 2021 May; 320(5):C669-C680. PubMed ID: 33356942
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Antisense oligonucleotides as therapeutics for malignant diseases.
    Ho PT; Parkinson DR
    Semin Oncol; 1997 Apr; 24(2):187-202. PubMed ID: 9129689
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.